Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells
Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells is a paper indexed in PICO Portal from OpenAlex.
How many citations does Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells have?
Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells has 45 citations in the OpenAlex counts PICO Portal stores.
When was Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells published?
Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells has 2018 year in the PICO Portal index.
What is the open-access status of Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells?
Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells has gold oa status in the PICO Portal index.
What is the DOI of Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells?
The DOI for Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells is on the source record.
What is the PMID of Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells?
The PMID for Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells is on the source record.
What is the OpenAlex record for Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells?
The OpenAlex for Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells is on the source record.